El Abdellati Kawtar, De Picker Livia, Morrens Manuel
Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium.
Scientific Institute for Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium.
Front Neurosci. 2020 Oct 9;14:531763. doi: 10.3389/fnins.2020.531763. eCollection 2020.
Antipsychotic medication non-adherence has detrimental effects on patients' clinical outcome. It is unclear which risk factors affect adherence most and which interventions are effective at improving adherence to antipsychotic medication. The aim of this systematic review is to summarize evidence exploring risk factors of non-adherence to antipsychotic treatment and effectiveness of intervention to improve adherence in patients with psychotic spectrum disorders. We conducted a systematic search in PubMed from 1994 to 2019 using a structured search strategy. Studies were quality assessed, and studies reporting on possible risk factors and intervention strategies were synthesized. We reviewed 26 studies on factors related to antipsychotic medication adherence and 17 studies on interventions to improve adherence in patients with psychosis spectrum disorders. Risk factors of non-adherence included younger age, poor illness insight, cannabis abuse, and the presence of severe positive symptoms. Antipsychotic medication adherence was associated with positive attitude toward medication of both patients and their family, family involvement, and illness insight. Somewhat consistent evidence was found for interventions involving family and technology-based interventions and strategies combining depot medication with psychoeducation. However, given the wide range of heterogeneous interventions and methodological limitations, findings must be interpreted with caution. Despite much effort invested in the research area of antipsychotic medication adherence, the heterogeneity in study design and outcome, adding to confounding effects and possible biases, and methodological restraints complicate comparability of the results. Future research in this field should therefore be conducted on patient-tailored interventions, considering risk factors affecting the patient and implementing well-validated, standardized assessment methods. Accordingly, this systematic review seeks to facilitate endeavors improving adherence to antipsychotic treatment by identifying modifiable and non-modifiable risk factors, outlining effective intervention strategies, and proposing recommendations to enhance adherence strategies.
抗精神病药物治疗依从性不佳会对患者的临床结局产生不利影响。目前尚不清楚哪些风险因素对依从性影响最大,以及哪些干预措施能有效提高抗精神病药物的依从性。本系统评价的目的是总结探索抗精神病治疗依从性风险因素及改善精神分裂症谱系障碍患者依从性干预措施有效性的证据。我们使用结构化检索策略在1994年至2019年的PubMed数据库中进行了系统检索。对研究进行了质量评估,并综合了报告可能风险因素和干预策略的研究。我们回顾了26项关于抗精神病药物依从性相关因素的研究以及17项关于改善精神分裂症谱系障碍患者依从性干预措施的研究。依从性不佳的风险因素包括年龄较小、疾病自知力差、大麻滥用以及存在严重的阳性症状。抗精神病药物依从性与患者及其家属对药物的积极态度、家庭参与度和疾病自知力相关。对于涉及家庭和基于技术的干预措施以及长效药物与心理教育相结合的策略,发现了一些较为一致的证据。然而,鉴于干预措施种类繁多且存在异质性以及方法学上的局限性,研究结果必须谨慎解读。尽管在抗精神病药物依从性研究领域投入了大量精力,但研究设计和结果的异质性,加上混杂效应和可能的偏倚,以及方法学限制,使得结果的可比性变得复杂。因此,该领域未来的研究应针对患者量身定制干预措施,考虑影响患者的风险因素,并采用经过充分验证的标准化评估方法。相应地,本系统评价旨在通过识别可改变和不可改变的风险因素、概述有效的干预策略以及提出增强依从性策略的建议,来促进提高抗精神病治疗依从性的努力。